Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

OBLN - Obalon Therapeutics Inc


Previous close
9.15
0   0%

Share volume: 0
Last Updated: Tue 15 Jun 2021 06:00:00 AM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$9.15
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Fundamental analysis
25%
Profitability 25%
Dept financing 20%
Liquidity 29%
Performance 25%
Company vs Stock growth
vs
Performance
5 Days
-8.68%
1 Month
27.62%
3 Months
-16.67%
6 Months
98.03%
1 Year
211.86%
2 Year
-55.15%
Key data
Stock price
$9.15
P/E Ratio 
-2.72
DAY RANGE
$2.95 - $9.15
EPS 
-$1.38
52 WEEK RANGE
$0.66 - $10.77
52 WEEK CHANGE
$1.86
MARKET CAP 
91.697 M
YIELD 
N/A
SHARES OUTSTANDING 
10.022 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
2.10
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,362,437
AVERAGE 30 VOLUME 
$7,631,284
Company detail
CEO: Andrew Rasdal
Region: US
Website: www.obalon.com
Employees: 0
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Obalon Therapeutics, Inc. is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.

Recent news